Author:
Kumar Ravindra,Singh Mukesh Vir,Shrivastava Anubha,Yadav Rajesh Kumar,Siddiqui Shahid Akhtar,Sachan Reena,Maurya Manisha,Mishra Nandita,Shukla Santosh Kumar,Sonkar Madhu
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. UNAIDS Global AIDS update 2021: Confronting inequalities. Accessed on Feb 07, 2024. Available from: https://www.unaids.org/sites/default/files/media_asset/2021-global-aids-update_en.pdf
2. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach, 2nd ed. Geneva: WHO; 2013. Accessed on Feb 07, 2024. Available from: https://www.who.int/publications/i/item/9789241549684
3. Gallant JE, Deresinski S. Tenofovir disoproxil fumarate. Clin Infect Dis. 2003;37:944–50.
4. Wishart DS, Knox C, Guo AC, et al. Drug Bank: a knowledge base for drugs, drug actions and drug targets. Nucleic Acids Res. 2008;36:D901–6.
5. Hall AM, Hendry BM, Nitsch D, Connolly JO. Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis. 2011;57:773–80.